St. Paul-based Spineology Inc. announced Tuesday that it has received FDA approval for a line of new fusion implant devices that are designed to treat chronic back pain.
The 15-year-old company specializes in meshes, graft materials and other minimally invasive surgical-products that preserve backbone and tissue.
With new FDA approval, Spineology will launch its new Rampart line of implant tools, which are expected to enhance surgeons' ability to position implants within a patient's disc.
Spineology last received FDA approval in 2009 for its Capture Facet Screw System. The young med tech firm raised $9 million in venture capital funding in 2008.
Company officials were not immediately available Tuesday morning.
Dee DePass • 612-673-7725
